Clinical Trial Detail

NCT ID NCT02762981
Title Study to Evaluate CORT125134 in Combination With Nab-paclitaxel in Patients With Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Corcept Therapeutics
Indications

ovarian cancer

peritoneum cancer

fallopian tube cancer

Advanced Solid Tumor

triple-receptor negative breast cancer

Therapies

Nab-paclitaxel + Relacorilant

Age Groups: adult senior

No variant requirements are available.